Joline S J Lim

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Oxide Nanoparticles

Preterm Infants

Top Venues

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Jerold Loh, Jiaxuan Wu, Jenny Chieng, Aurora Chan, Wei-Peng Yong, Raghav Sundar, Soo-Chin Lee, Andrea Wong, Joline S J Lim, David S P Tan, Ross Soo, Boon-Cher Goh, Bee-Choo Tai, Cheng Ean Chee
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials. British journal of cancer (2023)
Robert J Walsh, Raghav Sundar, Joline S J Lim
Immune checkpoint inhibitor combinations-current and emerging strategies. British journal of cancer (2023)
Joline S J Lim, Andrea L A Wong, Samuel Guan Wei Ow, Natalie Yan Li Ngoi, Gloria H J Chan, Yvonne L E Ang, Wan Qin Chong, Siew Eng Lim, Yi Wan Lim, Matilda X Lee, Joan R E Choo, Hon Lyn Tan, Wei Peng Yong, Ross Andrew Soo, David Shao Peng Tan, Cheng Ean Chee, Raghav Sundar, Kritika Yadav, Supriya Jain, Ling-Zhi Wang, Bee Choo Tai, Boon Cher Goh, Soo-Chin Lee
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Javier Pascual, Joline S J Lim, Iain R J Macpherson, Anne C Armstrong, Alistair Ring, Alicia F C Okines, Rosalind J Cutts, Maria Teresa Herrera-Abreu, Isaac Garcia-Murillas, Alex Pearson, Sarah Hrebien, Heidrun Gevensleben, Paula Z Proszek, Michael Hubank, Margaret Hills, Jenny King, Mona Parmar, Toby Prout, Laura Finneran, Jason Malia, Karen E Swales, Ruth Ruddle, Florence I Raynaud, Alison Turner, Emma C Hall, Timothy Anthony Yap, Juanita S Lopez, Nicholas C Turner
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers. Cancer discovery 11 (1) (2020)